Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted R Mikuls

Showing results (11-20 of 387) with videos related to

Pageof 39
Sort By:
Arthritis and Rheumatism|February 5, 2011
To improve outcomes we must define and measure them: toward defining remission in rheumatoid arthritisJames R O'Dell, Ted R Mikuls
Current Rheumatology Reports|May 28, 2005
Recent advances in the epidemiology of goutKenneth G Saag, Ted R Mikuls
Current Rheumatology Reports|October 9, 2003
Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritisTed R Mikuls, Arthur L Weaver
The American Journal of Managed Care|November 23, 2005
Understanding treatments for goutAmy C Cannella, Ted R Mikuls
The Journal of Rheumatology|August 3, 2016
The Problem with Gout Is That It's Still Such a ProblemBrian W Coburn, Ted R Mikuls
Rheumatic Diseases Clinics of North America|November 4, 2022
Environmental Triggers of Hyperuricemia and GoutLindsay N Helget, Ted R Mikuls
Current Opinion in Rheumatology|February 21, 2018
Recent advances in the treatment of rheumatoid arthritisTina D Mahajan, Ted R Mikuls
Current Opinion in Rheumatology|December 22, 2023
Health disparities in goutLindsay N Helget, Ted R Mikuls
Drug Safety|December 24, 2002
Benefit-risk assessment of infliximab in the treatment of rheumatoid arthritisTed R Mikuls, Larry W Moreland
Current Rheumatology Reports|May 28, 2005
Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?Ted R Mikuls, Kenneth G Saag
Pageof 39

Showing results (11-20 of 387) with videos related to

Sort By:
Pageof 39
Arthritis and Rheumatism|February 5, 2011
To improve outcomes we must define and measure them: toward defining remission in rheumatoid arthritisJames R O'Dell, Ted R Mikuls
Current Rheumatology Reports|May 28, 2005
Recent advances in the epidemiology of goutKenneth G Saag, Ted R Mikuls
Current Rheumatology Reports|October 9, 2003
Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritisTed R Mikuls, Arthur L Weaver
The American Journal of Managed Care|November 23, 2005
Understanding treatments for goutAmy C Cannella, Ted R Mikuls
The Journal of Rheumatology|August 3, 2016
The Problem with Gout Is That It's Still Such a ProblemBrian W Coburn, Ted R Mikuls
Rheumatic Diseases Clinics of North America|November 4, 2022
Environmental Triggers of Hyperuricemia and GoutLindsay N Helget, Ted R Mikuls
Current Opinion in Rheumatology|February 21, 2018
Recent advances in the treatment of rheumatoid arthritisTina D Mahajan, Ted R Mikuls
Current Opinion in Rheumatology|December 22, 2023
Health disparities in goutLindsay N Helget, Ted R Mikuls
Drug Safety|December 24, 2002
Benefit-risk assessment of infliximab in the treatment of rheumatoid arthritisTed R Mikuls, Larry W Moreland
Current Rheumatology Reports|May 28, 2005
Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?Ted R Mikuls, Kenneth G Saag
Pageof 39